サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：トリプタミンAPIの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- グレード別、原料別、用途別、地域別
市場調査レポート
商品コード
1397319

トリプタミンAPIの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- グレード別、原料別、用途別、地域別

Tryptamines API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 289 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
トリプタミンAPIの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- グレード別、原料別、用途別、地域別
出版日: 2023年12月11日
発行: Fairfield Market Research
ページ情報: 英文 289 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のトリプタミンAPI（医薬品原薬）の市場規模は大幅な成長を遂げ、2024年には6億3,000万米ドルの収益を記録するとみられています。同市場は急速な拡大を続け、2031年末までに1兆6,500億米ドルの評価額に達すると予測されています。

トリプタミンAPI市場は、片頭痛障害の有病率の上昇、トリプタミンの潜在的な抗がん作用、神経疾患や精神疾患における治療用としてのトリプタミンの探求など、いくつかの要因により成長を遂げています。特に北米では、トリプタミンAPIが片頭痛やその他の神経疾患の治療にますます利用されるようになっているため、特殊な医薬品に対するニーズがトリプタミンAPI市場の成長に寄与しています。

片頭痛は最も一般的な神経疾患の一つであり、年間10億人以上が罹患しています。片頭痛の発症は複雑で、さまざまな社会的・生物学的危険因子もあることから、効果的な治療法に対する需要が高まっており、トリプタミンAPI市場を牽引しています。トリプタミン・サイケデリックを含む精神作用性化学物質の神経学的効果に関する調査は、その治療的可能性が認識されたことから増加しています。様々な神経疾患や精神疾患の治療に対するトリプタミンの探求は、市場の成長を促進すると予想されます。

当レポートでは、世界のトリプタミンAPI市場について調査し、市場の概要とともに、グレード別、原料別、用途別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 生産高と貿易統計、2018年～2023年

第4章 価格分析、2018年～2023年

第5章 世界のトリプタミンAPI市場の見通し、2018年～2031年

  • 世界のトリプタミンAPI市場の見通し、グレード別、金額（10億米ドル）、数量（kg）、2018年～2031年
  • 世界のトリプタミンAPI市場の見通し、原料別、金額（10億米ドル）、数量（kg）、2018年～2031年
  • 世界のトリプタミンAPI市場の見通し、用途別、金額（10億米ドル）、数量（kg）、2018年～2031年
  • 世界のトリプタミンAPI市場の見通し、地域別、金額（米国米ドル）、数量（kg）、2018年～2031年

第6章 北米のトリプタミンAPI市場の見通し、2018年～2031年

第7章 欧州のトリプタミンAPI市場の見通し、2018年～2031年

第8章 アジア太平洋のトリプタミンAPI市場の見通し、2018年～2031年

第9章 ラテンアメリカのトリプタミンAPI市場の見通し、2018年～2031年

第10章 中東・アフリカのトリプタミンAPI市場の見通し、2018年～2031年

第11章 競合情勢

  • エンドユーザー別と原料別のヒートマップ
  • メーカーと原料別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Merck
    • Avra Synthesis Private Limited
    • Spectrum Chemical
    • Cayman Chemical Company (Matreya)
    • Tokyo Chemical Industry Co. Ltd.
    • Santa Cruz Biotechnology, Inc.
    • LGC Standards
    • Avra Synthesis Private Limited
    • SimSon Pharma Limited
    • Glentham Life

第12章 付録

目次

The Global Tryptamines API (Active Pharmaceutical Ingredient) Market has witnessed substantial growth, recording revenue of US$ 630 million in 2024. The market is projected to continue its rapid expansion, aiming to reach a valuation of US$ 1650 billion by the end of 2031, according to a recent report released by Fairfield Market Research.

Key Market Highlights:

  • Tryptamines and Their Significance: Tryptamines are monoamine alkaloids found in mammals, fungi, and plants, with structural similarities to the amino acid tryptophan. They serve as the foundation for various biologically active substances, including psychedelic drugs and neurotransmitters.
  • Market Growth Drivers: The market for Tryptamines APIs is experiencing growth due to several factors, including the rising prevalence of migraine disorders, the potential anti-cancer effects of tryptamine, and the exploration of tryptamines for therapeutic use in neurological and psychiatric conditions.
  • Demand for Specialized Pharmaceuticals: The need for specialized pharmaceuticals, particularly in North America, has contributed to the growth of the Tryptamines API market, as these APIs are increasingly utilized in the treatment of migraine and other neurological conditions.

Factors Fueling Market Growth:

  • Prevalence of Migraine Disorders: Migraine is one of the most common neurological disorders, affecting over one billion people annually. The complexity of migraine development, along with various social and biological risk factors, has led to an increased demand for effective treatments, driving the market for Tryptamines APIs.
  • Psychoactive Chemicals and Therapeutic Potential: Research into the neurological effects of psychoactive chemicals, including tryptamine psychedelics, has grown due to their perceived therapeutic potential. The exploration of tryptamines for treating various neurological and psychiatric conditions is expected to fuel market growth.

Challenges Affecting Market Growth:

  • High Capital Investment: The manufacturing of Tryptamines APIs involves significant capital investment due to various factors, including infrastructure, equipment, and quality standards. These high capital requirements may hinder market growth.

Key Market Dynamics:

  • United States Market Surge: North America, particularly the United States, is expected to dominate the Tryptamines API market due to the region's increasing demand for specialized pharmaceuticals and the high prevalence of migraine disorders.
  • Germany's Lucrative Market: Germany offers numerous advantages for Tryptamines API manufacturers, including investments in R&D projects and the presence of significant regional market participants.
  • China's Growing Market: China is becoming a prominent market for Tryptamines APIs, with Chinese API producers obtaining globally recognized Good Manufacturing Practice (GMP) accreditation.

Highly Sought-after API Grade: GMP-grade Tryptamines APIs, produced in compliance with established quality standards for clinical use, are in high demand.

Preferred Source of Tryptamines APIs: Synthetic chemical APIs, known as small molecules, are widely used in the pharmaceutical industry. They include medications like sumatriptan, ondansetron, and alosetron.

Competitive Landscape:

Major market players are focusing on expansion strategies to tap into potential markets, emphasizing the mass production of GMP-compliant products with market potential in underdeveloped regions.

Key Companies in the Market:

  • Merck
  • Spectrum Chemical
  • LGC Standards
  • Cayman Chemical Company (Matreya)
  • Psygen
  • Biosynth
  • Clearsynth Labs
  • Glentham Life
  • Pharmaffiliates Analytics and Synthetics P. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • SimSon Pharma Limited
  • Otto Chemie Pvt. Ltd
  • Tokyo Chemical Industry Co. Ltd.
  • Avra Synthesis Private Limited

Market Segmentation

Grade:

  • GMP Grade
  • Non-GMP Grade

Source:

  • Natural
  • Synthetic
  • Bio-Synthetic

Application:

  • Clinical Use
  • Research Use

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Tryptamines API Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Tryptamines API Market Production Output, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Grade/ Material, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Peripheral Stent Implants Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Tryptamines API Market Outlook, 2018 - 2031

  • 5.1. Global Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. GMP Grade
      • 5.1.1.2. Non-GMP Grade
  • 5.2. Global Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Natural
      • 5.2.1.2. Synthetic
      • 5.2.1.3. Bio-Synthetic
  • 5.3. Global Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Clinical Use
      • 5.3.1.2. Research Use
  • 5.4. Global Tryptamines API Market Outlook, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Tryptamines API Market Outlook, 2018 - 2031

  • 6.1. North America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. GMP Grade
      • 6.1.1.2. Non-GMP Grade
  • 6.2. North America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
      • 6.2.1.3. Bio-Synthetic
  • 6.3. North America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Clinical Use
      • 6.3.1.2. Research Use
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.2. U.S. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.3. U.S. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.4. Canada Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.5. Canada Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.6. Canada Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Tryptamines API Market Outlook, 2018 - 2031

  • 7.1. Europe Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. GMP Grade
      • 7.1.1.2. Non-GMP Grade
  • 7.2. Europe Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Natural
      • 7.2.1.2. Synthetic
      • 7.2.1.3. Bio-Synthetic
  • 7.3. Europe Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Clinical Use
      • 7.3.1.2. Research Use
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.2. Germany Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.3. Germany Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.4. U.K. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.5. U.K. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.6. U.K. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.7. France Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.8. France Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.9. France Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.10. Italy Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.11. Italy Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.12. Italy Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.13. Turkey Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.14. Turkey Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.15. Turkey Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.16. Russia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.17. Russia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.18. Russia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.19. Rest of Europe Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.20. Rest of Europe Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.21. Rest of Europe Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Tryptamines API Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. GMP Grade
      • 8.1.1.2. Non-GMP Grade
  • 8.2. Asia Pacific Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Natural
      • 8.2.1.2. Synthetic
      • 8.2.1.3. Bio-Synthetic
  • 8.3. Asia Pacific Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Clinical Use
      • 8.3.1.2. Research Use
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.2. China Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.3. China Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.4. Japan Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.5. Japan Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.6. Japan Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.7. South Korea Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.8. South Korea Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.9. South Korea Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.10. India Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.11. India Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.12. India Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.13. Southeast Asia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.14. Southeast Asia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.15. Southeast Asia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Tryptamines API Market Outlook, 2018 - 2031

  • 9.1. Latin America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. GMP Grade
      • 9.1.1.2. Non-GMP Grade
  • 9.2. Latin America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.2.1.1. Natural
    • 9.2.1.2. Synthetic
    • 9.2.1.3. Bio-Synthetic
  • 9.3. Latin America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Clinical Use
      • 9.3.1.2. Research Use
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.2. Brazil Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.3. Brazil Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.4. Mexico Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.5. Mexico Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.6. Mexico Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.7. Argentina Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.8. Argentina Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.9. Argentina Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Tryptamines API Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. GMP Grade
      • 10.1.1.2. Non-GMP Grade
  • 10.2. Middle East & Africa Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Natural
      • 10.2.1.2. Synthetic
      • 10.2.1.3. Bio-Synthetic
  • 10.3. Middle East & Africa Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Clinical Use
      • 10.3.1.2. Research Use
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.2. GCC Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.3. GCC Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.4. South Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.5. South Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.6. South Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.7. Egypt Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.8. Egypt Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.9. Egypt Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.10. Nigeria Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.11. Nigeria Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.12. Nigeria Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Source Heat map
  • 11.2. Manufacturer vs by Source Heatmap
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Merck
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Avra Synthesis Private Limited
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Spectrum Chemical
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Cayman Chemical Company (Matreya)
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Tokyo Chemical Industry Co. Ltd.
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Santa Cruz Biotechnology, Inc.
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. LGC Standards
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development
    • 11.5.8. Avra Synthesis Private Limited
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Product Portfolio
      • 11.5.8.3. Financial Overview
      • 11.5.8.4. Business Strategies and Development
    • 11.5.9. SimSon Pharma Limited
      • 11.5.9.1. Company Overview
      • 11.5.9.2. Product Portfolio
      • 11.5.9.3. Financial Overview
      • 11.5.9.4. Business Strategies and Development
    • 11.5.10. Glentham Life
      • 11.5.10.1. Company Overview
      • 11.5.10.2. Product Portfolio
      • 11.5.10.3. Financial Overview
      • 11.5.10.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations